BMC ophthalmology · 2026
Flanged scleral fixation: thermoplastic properties of suture materials and implications for flange geometry.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Parlak Melih, Werner Jens Ulrich, Cinar Muhammet, Wolf Armin
Аннотация
BACKGROUND: Flanged scleral fixation techniques are increasingly used in the management of intraocular lens dislocation and aphakia. However, complications such as conjunctival erosion and scleral migration remain a concern. Flange geometry may play a critical role in anchoring stability. This study investigates the thermoplastic properties of various suture materials to identify optimal conditions for flange formation.
METHODS: A disposable electrocautery device with a power supply and tip temperature of 392 °C was used for standardised application. Seven suture materials were used: polypropylene (6/0), polyamide 6 (6/0), polyamide 6.6 (6/0), vinylidene fluoride-co-hexafluoropropylene (PVDF) (6/0), polyester (5/0), and polytetrafluoroethylene (PTFE) (5/0 and 6/0). All sutures were heated 0.5, 1, 2, 3, 4, and 5 mm from the distal end and examined in 4 repeat measurements. The prepared flanges were photographed and measured using a digital microscope. The flange dimensions and geometry were assessed. Ratios of flange width to flange length and flange width to suture diameter were calculated.
RESULTS: All suture materials except polyamide 6.6 (6/0) and PTFE (5/0) formed a flange shape due to the increase in temperature as demonstrated by repeated measurements with a high degree of reproducibility. While polypropylene and PVDF took on a mushroom/rhomboid shape, the flange shape of polyamide 6 and polyester was spherical. The flange geometry of PTFE was funnel-shaped with sharp edges. With increasing duration of heat exposure, the flange length of polypropylene and PVDF increased more significantly than the flange width.
CONCLUSION: Polypropylene and PVDF demonstrate favorable thermoplastic properties for flanged scleral fixation, enabling reproducible flange formation with short heating times. A heating length of approximately 1 mm appears optimal for controlled flange geometry. Further biomechanical and in vivo studies are required to validate clinical performance.
METHODS: A disposable electrocautery device with a power supply and tip temperature of 392 °C was used for standardised application. Seven suture materials were used: polypropylene (6/0), polyamide 6 (6/0), polyamide 6.6 (6/0), vinylidene fluoride-co-hexafluoropropylene (PVDF) (6/0), polyester (5/0), and polytetrafluoroethylene (PTFE) (5/0 and 6/0). All sutures were heated 0.5, 1, 2, 3, 4, and 5 mm from the distal end and examined in 4 repeat measurements. The prepared flanges were photographed and measured using a digital microscope. The flange dimensions and geometry were assessed. Ratios of flange width to flange length and flange width to suture diameter were calculated.
RESULTS: All suture materials except polyamide 6.6 (6/0) and PTFE (5/0) formed a flange shape due to the increase in temperature as demonstrated by repeated measurements with a high degree of reproducibility. While polypropylene and PVDF took on a mushroom/rhomboid shape, the flange shape of polyamide 6 and polyester was spherical. The flange geometry of PTFE was funnel-shaped with sharp edges. With increasing duration of heat exposure, the flange length of polypropylene and PVDF increased more significantly than the flange width.
CONCLUSION: Polypropylene and PVDF demonstrate favorable thermoplastic properties for flanged scleral fixation, enabling reproducible flange formation with short heating times. A heating length of approximately 1 mm appears optimal for controlled flange geometry. Further biomechanical and in vivo studies are required to validate clinical performance.